logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Benign Prostatic Hyperplasia

    Medications for Benign Prostatic Hyperplasia

    FiltersReset Filters
    18 results

    • alfuzosin hydrochloride

      (Alfuzosin Hydrochloride)
      Rising Pharma Holdings, Inc.
      Usage: Alfuzosin hydrochloride extended-release tablets are indicated for treating signs and symptoms of benign prostatic hyperplasia. They are not intended for hypertension treatment or pediatric use.

    • cardura

      (doxazosin mesylate)
      ROERIG
      Usage: CARDURA is indicated for the treatment of benign prostatic hyperplasia (BPH) and hypertension. It helps alleviate BPH symptoms and lowers blood pressure, reducing the risk of cardiovascular events like strokes and heart attacks, and can be used alone or with other antihypertensive medications.

    • cardura

      (doxazosin)
      Viatris Specialty LLC
      Usage: CARDURA is indicated for the treatment of Benign Prostatic Hyperplasia (BPH) and hypertension. It helps alleviate symptoms of BPH and lowers blood pressure, thereby reducing the risk of fatal and nonfatal cardiovascular events, including strokes and myocardial infarctions. It can be used alone or with other antihypertensives.

    • cialis

      (Tadalafil)
      Eli Lilly and Company
      Usage: CIALIS® is indicated for the treatment of erectile dysfunction (ED) and the signs and symptoms of benign prostatic hyperplasia (BPH). It may be used for both conditions together, but the combination treatment with finasteride should not exceed 26 weeks due to diminishing benefits.

    • finasteride

      (Finasteride)
      Teva Pharmaceuticals USA, Inc.
      Usage: Finasteride is indicated for treating symptomatic benign prostatic hyperplasia (BPH) in men, improving symptoms, and reducing the risk of acute urinary retention and surgery. It can also be used with the alpha-blocker doxazosin to reduce symptomatic progression of BPH. It is not approved for prostate cancer prevention.

    • silodosin

      (Silodosin)
      AvKARE
      Usage: Silodosin is indicated for treating the signs and symptoms of benign prostatic hyperplasia (BPH). It is not intended for hypertension treatment.

    • silodosin

      (Silodosin)
      Ajanta Pharma USA Inc.
      Usage: Silodosin capsules are indicated for treating the signs and symptoms of benign prostatic hyperplasia (BPH). They are not intended for hypertension treatment.

    • tadalafil

      (Tadalafil)
      Accord Healthcare Inc.
      Usage: Tadalafil tablets are indicated for the treatment of erectile dysfunction (ED) and the signs and symptoms of benign prostatic hyperplasia (BPH). They can also be used for patients with both ED and BPH. Use with finasteride for BPH is recommended for up to 26 weeks.

    • tadalafil

      (Tadalafil)
      Quallent Pharmaceuticals Health LLC
      Usage: Tadalafil tablets are indicated for the treatment of erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and the combined condition of ED and BPH. Use with finasteride for BPH is recommended for up to 26 weeks due to diminishing benefits beyond this period.

    • tadalafil

      (Tadalafil)
      NIVAGEN PHARMACEUTICALS, INC.
      Usage: Tadalafil tablets are indicated for the treatment of erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and both ED and BPH (ED/BPH). Use with finasteride for BPH is recommended for up to 26 weeks due to decreasing incremental benefits.